Tectonic Therapeutic Overview
- Founded
- 2020

- Status
- Private
- Employees
- 9

- Latest Deal Type
- Grant
- Latest Deal Amount
- $75K

- Investors
- 2
Tectonic Therapeutic General Information
Description
Operator of a clinical biotechnology company intended to develop novel GPCR-targeted therapies. The company specializes in the research and development of therapeutics that address clinical challenges relevant to a broad range of patients suffering from cardiovascular diseases, dysregulated inflammation and other conditions, enabling the healthcare industry to improve the medical procedures in an efficient manner.
Contact Information
- 1 Sylvan Road
- Wellesley, MA 02481
- United States
Tectonic Therapeutic Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Grant | 21-May-2020 | $75K | Completed | Startup | ||
1. Early Stage VC | 01-Jan-2020 | Completed | Startup |
Tectonic Therapeutic Executive Team (4)
Tectonic Therapeutic Board Members (2)
Name | Representing | Role | Since |
---|---|---|---|
Andrew Kruse | Tectonic Therapeutic | Chief Financial Officer & Board Member | 000 0000 |
Christian Cortis Ph.D | Self | Chief Operating Officer & Board Member | 000 0000 |
Tectonic Therapeutic Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialTectonic Therapeutic Investors (2)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Harvard President's Challenge | University | 000 0000 | 000000 0 | ||
Polaris Partners | Venture Capital | Minority | 000 0000 | 000000 0 |